Recent Progress in Dendritic Cell-Based Cancer Immunotherapy

SIMPLE SUMMARY: Cancer immunotherapy has now attracted much attention because of the recent success of immune checkpoint inhibitors. However, they are only beneficial in a limited fraction of patients most probably due to lack of sufficient CD8+ cytotoxic T-lymphocytes against tumor antigens in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsuo, Kazuhiko, Yoshie, Osamu, Kitahata, Kosuke, Kamei, Momo, Hara, Yuta, Nakayama, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161242/
https://www.ncbi.nlm.nih.gov/pubmed/34065346
http://dx.doi.org/10.3390/cancers13102495

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161242/
https://www.ncbi.nlm.nih.gov/pubmed/34065346
http://dx.doi.org/10.3390/cancers13102495

Ejemplares similares